Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
about
Fixed-dose single tablet antidiabetic combinationsCardiovascular outcomes in trials of oral diabetes medications: a systematic reviewTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusSodium-glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin-metforminCardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing populationPeripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomesCardiovascular riskPharmacologic management of chronic reno-cardiac syndromeBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesWhy do some patients with type 1 diabetes live so long?Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysisRecent topics in chemical and clinical research on glycated albuminMonounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analysesEfficacy of intensive control of glucose in stroke prevention: a meta-analysis of data from 59,197 participants in 9 randomized controlled trialsCinnamon use in type 2 diabetes: an updated systematic review and meta-analysisUpdate on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Evidence for current diagnostic criteria of diabetes mellitusEvidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelinesSerum glucose control in diabetic patients with cardiovascular disease: should we be less aggressive?The associations between serum biomarkers and stenosis of the coronary arteriesOral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunctionCardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetesEffects of intensive glucose lowering in type 2 diabetesPeripheral artery disease: epidemiology and global perspectives.Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 Diabetes in Canada.Targets and tactics: the relative importance of HbA, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes.Bariatric and Metabolic Surgery in Adolescents: a Path to Decrease Adult Cardiovascular Mortality.The glucose triad and its role in comprehensive glycaemic control: current status, future management.Sleep apnea and diabetes: insights into the emerging epidemic.Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.Lessons learned from glycemia control studies.Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trialAssociation of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus.Improving interMediAte risk management. MARK studyGlycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older womenSystemic correlates of angiographic coronary artery disease.Efficacy of combined use of miglitol in Type 2 diabetes patients receiving insulin therapy-placebo-controlled double-blind comparative study.
P2860
Q22242410-005F5890-E211-4F1D-9AFB-D2D5D1BDC80AQ22253058-9745B82A-2010-4DC0-BB31-8585DC3C67ECQ24186667-D751B0A5-9D9C-4103-BB10-161487633DCEQ24202505-61D814C1-DBAE-4992-AFDE-1C14B2164154Q24236456-7DE4D375-1A44-4453-B0C0-B7291923D764Q26752815-2C4E4656-99C6-4193-B675-E46386F26349Q26777077-BBB63211-6E16-409E-821A-4FDBEF99C70EQ26799591-11D885F4-BB10-4943-A819-3FE7C63F19A1Q26825634-805FBC0A-D08A-44CA-AD72-64CB262DA8E8Q26829812-A90795B5-CCD4-4819-BD6A-34EEB08D4F02Q26853571-003CA4B1-CB22-4D95-8ABB-6623E5EB6ED8Q26858877-2547B333-721C-4BCA-959B-A1C4717938E4Q26860467-AA02CB30-B2BF-4356-8F1F-A7F66AC11BAEQ26865088-CB9A2B7A-E286-4FEF-8DE9-9706EE99788BQ26998824-DD2C2EEA-F64E-4F0D-9391-F4028172FD46Q27008807-D18ADDFF-4F43-4EE7-A0D9-58C42EE7A8DEQ27022291-32FBAA61-9E67-410F-B202-521A579A4F0BQ27687851-D68C0B24-30A0-4E04-B059-2D751B53381DQ28073671-49F150C0-1348-463B-BA2A-1FEC3736179CQ28075473-787E780A-A8FA-4238-BE65-9E4EC7DEA07DQ28254202-741E16D0-4D7E-4266-84A1-7668DFE2D314Q28554584-D34D5483-40F1-4F5C-9E6B-3E6779F34B8EQ28569684-D547E24E-9112-46B4-AFAB-1131C84CFE1AQ28741419-B726FA64-2792-494C-BCA1-F6A54EC54766Q29547736-05F3CEC6-C342-4E99-BF13-84B32A5E7221Q30241154-39085635-7995-408D-AE81-33806B55466AQ30278856-836FE3DE-F6BE-4127-A50D-37D527A2C640Q30374513-414DBCE2-C803-4FA8-90D7-99ECAA95F97FQ30377144-B46F3324-18E7-4CCA-8E17-F88D7BF11976Q30393989-271DD196-A523-4727-8947-35E8C7CADE92Q30396132-AF18853A-546A-4BA0-A7CA-F473A8AEBE5CQ30426632-1D16D6DC-63D1-4E64-B854-DA3E918B3166Q30450712-2621CFA4-A01D-4287-A105-617A515935C4Q30499944-A589FC8C-F0F9-4595-BE9B-1B5691BEB727Q31013668-A6D22ED7-8DFC-452D-A47F-5BB4A3488B3DQ31033555-9D74532E-8819-4AB0-A32E-42DE72FE4970Q31107244-495D9C30-97AD-4264-A60B-ADDA61BE005DQ33296042-6D561625-4A7C-4D81-968F-ECCC393CC415Q33404072-0A79C178-385B-4902-9A0D-EA5411C5A7FFQ33447152-E212CF4D-5FAF-40DD-95A5-72DFC54FAF72
P2860
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
@ast
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
@en
type
label
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
@ast
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
@en
prefLabel
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
@ast
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
@en
P2093
P921
P1476
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
@en
P2093
Frederick L Brancati
Gail Berkenblit
Neil R Powe
Spyridon Marinopoulos
Tejal Rami
P304
P356
10.7326/0003-4819-141-6-200409210-00007
P407
P577
2004-09-01T00:00:00Z